AIRA Capital PCL (BKK:AIRA)

Ligand Pharmaceuticals Revenue

AIRA Capital PCL had revenue of 193.65M THB in the quarter ending March 31, 2025, a decrease of -22.72%. This brings the company's revenue in the last twelve months to 764.37M, down -2.62% year-over-year. In the year 2024, AIRA Capital PCL had annual revenue of 821.32M with 16.56% growth.

• Revenue (ttm): 764.37M
• Revenue Growth: -2.62%
• P/S Ratio: 10.74
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 8.21B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	821.32M	116.66M	16.56%
Dec 31, 2023	704.66M	-44.87M	-5.99%
Dec 31, 2022	749.53M	-184.14M	-19.72%
Dec 31, 2021	933.67M	103.28M	12.44%
Dec 31, 2020	830.39M	196.56M	31.01%